COVID-19 and Kidney Disease
Researchers studied predictors of acute kidney injury (AKI) and mortality in a population of US veterans with COVID-19.
What role do serum free thiols play in the ability of CKD patients to mount a humoral response to SARS-CoV-2 vaccination?
What is the specific impact of acute kidney injury (AKI) on in-hospital mortality among octogenarian patients with COVID-19?
In kidney and liver transplant recipients, steroids and mycophenolic acid were associated with COVID-19 hospitalization risk.
A study reported on dual-drug resistance in a kidney transplant patient who received sotrovimab and remdesivir for COVID-19.
Researchers investigated COVID-19 diagnoses and related hospitalization or death in dialysis patients.
Since the onset of the pandemic, cardiovascular complications have been seen in patients with CKD and COVID-19.
A study examined the association of COVID-19 disease vs vaccination with kidney function and glomerular disease activity.
Patients hospitalized with COVID-19 face increased risk for long-term adverse outcomes such as major adverse kidney events.
There was no association between kidneys from active COVID-19-positive donors procured in 2023 and higher odds of nonuse.
The pooled proportion of all serious adverse effects related to remdesivir was 2.9%.
Results of an analysis to characterize the sequelae of COVID-19 infection among kidney transplant recipients.
Advertisement
Advertisement
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.